CV
Cadrenal Therapeutics, Inc. Common Stock (CVKD)
NASDAQ·Healthcare·Biotechnology
$0.97
-0.53%
Mkt Cap $3.82M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$32.00
Range $32.00 – $32.00
Implied Upside
+3182.6%
Consensus $32.00 vs current $0.97